Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Biden says U.S. turning corner on COVID, but experts are worried that BA.2 is pushing cases higher in 15 states
10:38am, Friday, 01'st Apr 2022 MarketWatch
President Joe Biden said Wednesday the U.S. is turning the page on the COVID-19 pandemic, as his administration took the wraps off a website that aims to help Americans find tests, treatments and othe
Why Novavax Stock Dipped On Thursday
10:19pm, Thursday, 31'st Mar 2022 The Motley Fool
Two outwardly positive developments for the company weren't enough to prevent a minor investor sell-off.
Novavax (NVAX) Stock Moves -1.47%: What You Should Know
09:45pm, Thursday, 31'st Mar 2022 Zacks Investment Research
In the latest trading session, Novavax (NVAX) closed at $73.65, marking a -1.47% move from the previous day.
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
12:14pm, Thursday, 31'st Mar 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Amylyx Says FDA Committee Casts Negative Vote On ALS Drug
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX)
Why Is Novavax (NVAX) Down 5.9% Since Last Earnings Report?
03:30pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
Novavax (NVAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Charts You Have to See Before Buying Moderna
02:53pm, Wednesday, 30'th Mar 2022 The Motley Fool
Could the gravy train be coming to an end?
Is Novavax Stock a Buy Now?
10:00am, Wednesday, 30'th Mar 2022 The Motley Fool
Two catalysts lie ahead.
2 Reasons Why Novavax Investors Should Be Cautious
02:53pm, Tuesday, 29'th Mar 2022 The Motley Fool
There's reason to believe things aren't going exactly as planned.
Should You Buy Moderna? Look at These 2 Charts First.
10:00am, Tuesday, 29'th Mar 2022 The Motley Fool
They offer us clues about near-term and long-term revenue.
Moderna Could Have a Big Problem on Its Hands
09:56am, Tuesday, 29'th Mar 2022 The Motley Fool
The not-so-great side effects of Moderna's flu vaccine candidate could have greater implications.
Are These 2 Rivals Beating Pfizer and Moderna?
10:00am, Monday, 28'th Mar 2022 The Motley Fool
They're winning when it comes to orders.
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
12:00pm, Sunday, 27'th Mar 2022 The Motley Fool
Another player has stuffed its pipeline with many coronavirus candidates.
3 Ultra-Popular Stocks That Could Soar 120%, 51%, and 109%, Wall Street Says
12:00pm, Saturday, 26'th Mar 2022 The Motley Fool
There's reason for the optimism.
Airport-based study found first U.S. case of BA.2 subvariant of omicron in December
05:43pm, Friday, 25'th Mar 2022 MarketWatch
An airport-based COVID-19 surveillance program detected the first known U.S. case of the highly transmissible omicron BA.2 subvariant in December, according to a new study that was funded by the Cente
Why Moderna, BioNTech, and Novavax Stocks Are Tumbling Today
04:30pm, Friday, 25'th Mar 2022 The Motley Fool
Investors appear to be concerned that Uncle Sam won't foot the bill for additional COVID-19 vaccine purchases.
